Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 42


Prospective study of serial 18F-FDG PET and 18F-fluoride (18F-NaF) PET to predict time to skeletal related events, time-to-progression, and survival in patients with bone-dominant metastatic breast cancer.

Peterson LM, O'Sullivan J, Wu QV, Novakova-Jiresova A, Jenkins I, Lee JH, Shields A, Montgomery S, Linden HM, Gralow JR, Gadi VK, Muzi M, Kinahan PE, Mankoff DA, Specht JM.

J Nucl Med. 2018 May 10. pii: jnumed.118.211102. doi: 10.2967/jnumed.118.211102. [Epub ahead of print]


Functional Precision Medicine Identifies Novel Druggable Targets and Therapeutic Options in Head and Neck Cancer.

Xu C, Nikolova O, Basom RS, Mitchell RM, Shaw R, Moser RD, Park H, Gurley KE, Kao MC, Green CL, Schaub FX, Diaz RL, Swan HA, Jang IS, Guinney J, Gadi VK, Margolin AA, Grandori C, Kemp CJ, Méndez E.

Clin Cancer Res. 2018 Jun 15;24(12):2828-2843. doi: 10.1158/1078-0432.CCR-17-1339. Epub 2018 Mar 29.


Comprehensive statistical inference of the clonal structure of cancer from multiple biopsies.

Liu J, Halloran JT, Bilmes JA, Daza RM, Lee C, Mahen EM, Prunkard D, Song C, Blau S, Dorschner MO, Gadi VK, Shendure J, Blau CA, Noble WS.

Sci Rep. 2017 Dec 5;7(1):16943. doi: 10.1038/s41598-017-16813-4.


Diffusion-weighted MRI characteristics associated with prognostic pathological factors and recurrence risk in invasive ER+/HER2- breast cancers.

Amornsiripanitch N, Nguyen VT, Rahbar H, Hippe DS, Gadi VK, Rendi MH, Partridge SC.

J Magn Reson Imaging. 2018 Jul;48(1):226-236. doi: 10.1002/jmri.25909. Epub 2017 Nov 27.


Phase I/II Trial of Combined Pegylated Liposomal Doxorubicin and Cyclophosphamide in Metastatic Breast Cancer.

Chang AE, Wu QV, Jenkins IC, Specht JM, Gadi VK, Gralow JR, Salazar LG, Kurland BF, Linden HM.

Clin Breast Cancer. 2018 Feb;18(1):e143-e149. doi: 10.1016/j.clbc.2017.10.005. Epub 2017 Oct 9.


Practical Approach to Triple-Negative Breast Cancer.

Gadi VK, Davidson NE.

J Oncol Pract. 2017 May;13(5):293-300. doi: 10.1200/JOP.2017.022632. Review.


Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine.

Pauli C, Hopkins BD, Prandi D, Shaw R, Fedrizzi T, Sboner A, Sailer V, Augello M, Puca L, Rosati R, McNary TJ, Churakova Y, Cheung C, Triscott J, Pisapia D, Rao R, Mosquera JM, Robinson B, Faltas BM, Emerling BE, Gadi VK, Bernard B, Elemento O, Beltran H, Demichelis F, Kemp CJ, Grandori C, Cantley LC, Rubin MA.

Cancer Discov. 2017 May;7(5):462-477. doi: 10.1158/2159-8290.CD-16-1154. Epub 2017 Mar 22.


Systemic therapy of brain metastases: non-small cell lung cancer, breast cancer, and melanoma.

Chamberlain MC, Baik CS, Gadi VK, Bhatia S, Chow LQ.

Neuro Oncol. 2017 Jan;19(1):i1-i24. doi: 10.1093/neuonc/now197. Review.


Breast Cancer Outlook for 2017: Keeping the Accelerator to the Floor.

Gadi VK, Gralow JR.

Oncology (Williston Park). 2016 Dec 1;30(12 Suppl 2):1-2, 15. No abstract available.


Statistical Methods for Unusual Count Data: Examples From Studies of Microchimerism.

Guthrie KA, Gammill HS, Kamper-Jørgensen M, Tjønneland A, Gadi VK, Nelson JL, Leisenring W.

Am J Epidemiol. 2016 Nov 15;184(10):779-786. doi: 10.1093/aje/kww093.


Phase I Study of Veliparib (ABT-888) Combined with Cisplatin and Vinorelbine in Advanced Triple-Negative Breast Cancer and/or BRCA Mutation-Associated Breast Cancer.

Rodler ET, Kurland BF, Griffin M, Gralow JR, Porter P, Yeh RF, Gadi VK, Guenthoer J, Beumer JH, Korde L, Strychor S, Kiesel BF, Linden HM, Thompson JA, Swisher E, Chai X, Shepherd S, Giranda V, Specht JM.

Clin Cancer Res. 2016 Jun 15;22(12):2855-64. doi: 10.1158/1078-0432.CCR-15-2137. Epub 2016 Jan 22.


The Effect of Treatment Advances on the Mortality Results of Breast Cancer Screening Trials: A Microsimulation Model.

Birnbaum J, Gadi VK, Markowitz E, Etzioni R.

Ann Intern Med. 2016 Feb 16;164(4):236-43. doi: 10.7326/M15-0754. Epub 2016 Jan 12.


Adjuvant Endocrine Therapy in Patients with Ductal Carcinoma In Situ: A Population-Based Retrospective Analysis from 2005 to 2012 in the National Cancer Data Base.

Flanagan MR, Rendi MH, Gadi VK, Calhoun KE, Gow KW, Javid SH.

Ann Surg Oncol. 2015 Oct;22(10):3264-72. doi: 10.1245/s10434-015-4668-z. Epub 2015 Jul 23.


Adjuvant Metronomic CMF in a Contemporary Breast Cancer Cohort: What's Old Is New.

Cho E, Schwemm AK, Rubinstein LM, Stevenson PA, Gooley TA, Ellis GK, Specht JM, Livingston RB, Linden HM, Gadi VK.

Clin Breast Cancer. 2015 Oct;15(5):e277-85. doi: 10.1016/j.clbc.2015.04.002. Epub 2015 Apr 24.


The use of stereotactic radiosurgery for brain metastases from breast cancer: who benefits most?

Cho E, Rubinstein L, Stevenson P, Gooley T, Philips M, Halasz LM, Gensheimer MF, Linden HM, Rockhill JK, Gadi VK.

Breast Cancer Res Treat. 2015 Feb;149(3):743-9. doi: 10.1007/s10549-014-3242-x. Epub 2015 Feb 1.


Male microchimerism and survival among women.

Kamper-Jørgensen M, Hjalgrim H, Andersen AM, Gadi VK, Tjønneland A.

Int J Epidemiol. 2014 Feb;43(1):168-73. doi: 10.1093/ije/dyt230. Epub 2013 Dec 17.


Preoperative MRI improves prediction of extensive occult axillary lymph node metastases in breast cancer patients with a positive sentinel lymph node biopsy.

Loiselle C, Eby PR, Kim JN, Calhoun KE, Allison KH, Gadi VK, Peacock S, Storer BE, Mankoff DA, Partridge SC, Lehman CD.

Acad Radiol. 2014 Jan;21(1):92-8. doi: 10.1016/j.acra.2013.10.001.


A phase 2 study of 16α-[18F]-fluoro-17β-estradiol positron emission tomography (FES-PET) as a marker of hormone sensitivity in metastatic breast cancer (MBC).

Peterson LM, Kurland BF, Schubert EK, Link JM, Gadi VK, Specht JM, Eary JF, Porter P, Shankar LK, Mankoff DA, Linden HM.

Mol Imaging Biol. 2014 Jun;16(3):431-40. doi: 10.1007/s11307-013-0699-7. Epub 2013 Oct 30.


In situ breast cancer and microchimerism.

Eun JK, Guthrie KA, Zirpoli G, Gadi VK.

Sci Rep. 2013;3:2192. doi: 10.1038/srep02192.


Fetal cellular microchimerism in miscarriage and pregnancy termination.

Peterson SE, Nelson JL, Gadi VK, Gammill HS.

Chimerism. 2013 Oct-Dec;4(4):136-8. doi: 10.4161/chim.24915. Epub 2013 May 3.

Supplemental Content

Support Center